Teladoc Health, Inc.
Teladoc Health, Inc. (TDOC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
tdoc · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Teladoc Health, Inc. (TDOC) measures how much investors pay for each dollar of the company's trailing earnings. TDOC's current PE ratio of N/A is calculated by dividing its stock price of $7.05 by its TTM earnings per share of -$0.96.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2013 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Teladoc Health, Inc.You TDOC | $1.3B | N/A | — | -$0.96 |
 Azenta, Inc. AZTA | $1.0B | N/A | — | -$1.22 |
 Evotec SE EVO | $1.0B | N/A | — | -$0.28 |
 Immunome, Inc. IMNM | $1.8B | N/A | — | -$2.43 |
 NovoCure Limited NVCR | $2.0B | N/A | — | -$1.22 |
 Omnicell, Inc. OMCL | $1.9B | 1014.72x | — | $0.04 |
 Omada Health OMDA | $1.1B | N/A | — | -$0.22 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.14 | — | |
2024-12-31 FY2024 | — | $-5.87 | — | |
2023-12-31 FY2023 | — | $-1.36 | — | |
2022-12-31 FY2022 | — | $-84.60 | — | |
2021-12-31 FY2021 | — | $-2.73 | — | |
2020-12-31 FY2020 | — | $-5.36 | — | |
2019-12-31 FY2019 | — | $-1.38 | — | |
2018-12-31 FY2018 | — | $-1.47 | — | |
2017-12-31 FY2017 | — | $-1.93 | — | |
2016-12-31 FY2016 | — | $-1.75 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Teladoc Health, Inc. (TDOC) measures how much investors pay for each dollar of the company's trailing earnings. TDOC's current PE ratio of N/A is calculated by dividing its stock price of $7.05 by its TTM earnings per share of -$0.96.
Frequently asked questions
TDOC pe ratio · 6 questionsTDOC's current PE ratio is N/A as of 2026-06-08, based on a stock price of $7.05 and TTM EPS of -$0.96. Data sourced from Financial Modeling Prep via TDOC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Teladoc Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08